A Study to Evaluate the Efficacy and Safety of Monosialotetrahexosylganglioside Sodium Injection in Parkinson's Disease Participants With Motor Fluctuations
Clinical trial NCT07585565 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07585565
- Sponsor
- Qilu Pharmaceutical Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-01
- Primary completion
- 2028-03-01
- Enrollment
- 276
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.